From: Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
 | Airway epithelial cell type | |||
---|---|---|---|---|
 | SAE cells (Type I) | A549 (Type II) | ||
Cytokines (pg/ml media) | Mock | RSV | Mock | RSV |
IL-1β | 12.66±1.76 | 31.75±1.48* | 13.52±0.80 | 34.33±4.3* |
IL-1β | 9.55±1.17 | 15.50±2.45* | 1.28±0.05 | 2.28±0.45* |
IL1-RA | 40.37±6.37 | 63.25±4.82* | 5.20±0.37 | 23.28±3.88* |
IL-2 | 0.98±0.28 | 1.44±0.42 | 0.20±0.05 | 0.25±0.07 |
IL-2RA | 41.65±3.57 | 44.67±2.12 | 36.72±0.58 | 34.53±0.55 |
IL-3 | 102.7±8.85 | 100.2±7.37 | 59.09±3.54 | 58.08±4.56 |
IL-6 | 2349±234.6 | 3260±153.8* | 17.21±0.79 | 534.4±19.22* |
IL-7 | 29.36±4.87 | 55.37±8.32* | 17.00±4.57 | 34.44±4.15* |
IL-8/CXCL8 | 2479±154.4 | 5094±363.5* | 142.2±20.70 | 1203±83.75* |
IL-10 | 6.89±1.31 | 8.13±0.15 | 5.85±0.27 | 7.02±0.24* |
IL-12(p40) | 193.4±17.18 | 183.9±19.78 | 127.2±10.11 | 135.0±19.54 |
IL-12(p70) | 36.76±5.48 | 36.09±5.94 | 14.54±1.29 | 19.86±0.81* |
IL-16 | 115.7±14.5 | 223.5±19.04* | 652.1±32.79 | 387.5±45.97 |
IL-18 | 6.70±0.71 | 11.94±0.92* | 6.24±0.31 | 7.06±0.37 |
GROα/CXCL1 | 8482±428 | 11119±639* | 2431±177.7 | 9473±366.4* |
Eotaxin/CCL11 | 5.16±0.24 | 10.37±0.62* | 1.38±0.16 | 3.43±0.37* |
FGF | 6.60±0.30 | 10.72±1.41* | 4.24±0.51 | 13.92±2.16* |
G-CSF/CSF-3 | 945.6±72.01 | 1403±130.2 | 1.00±0.79 | 10.16±1.57* |
GM-CSF/CSF-2 | 9.74±2.99 | 10.04±3.15 | 3.73±0.44 | 7.12±0.51* |
M-CSF/CSF-1 | 73.03±8.60 | 98.50±6.41 | 2.90±0.74 | 4.55±0.63 |
IFN-γ2 | 4.62±0.32 | 4.97±0.27 | 4.46±0.04 | 4.55±0.76 |
IFN-γ | 95.39±13.08 | 171.6±12.04* | 12.38±1.98 | 81.81±8.88* |
MIG/CXCL9 | 29.01±3.91 | 61.41±2.99* | 53.83±5.43 | 104.81±12.11 |
IP10/CXCL10 | 337.6±93.99 | 10580±546* | 5.13±0.35 | 1836±97.5* |
MCP-1/CCL2 | 146.2±15.51 | 266.0±42.71* | 557.1±30.48 | 1088±56.54* |
MCP-3/CCL7 | 71.68±8.97 | 215.8±17.44* | 96.03±10.57 | 78.41±11.14 |
MIP-1β/CCL3 | 1.88±0.12 | 2.38±0.36 | 1.25±0.09 | 16.96±0.42* |
MIP-1β/CCL4 | 1.55±0.32 | 2.75±0.45 | 0.77±0.13 | 89.04±7.52* |
MIF | 2123±186.2 | 7435±179.5* | 454.0±20.8 | 1015±47.5* |
PDGF-BB | 6.91±1.01 | 16.90±2.98* | 3.68±0.59 | 10.23±0.16* |
RANTES/CCL5 | 206.8±10.32 | 339.9±29.54* | 44.30±8.53 | 656.9±82.5* |
TNF-α | 16.78±0.57 | 32.40±3.27* | 1.14±0.12 | 27.83±2.37* |
TNF-α/LTA | 21.98±1.39 | 21.09±0.78 | 17.59±0.18 | 17.41±0.72 |
VEGF | 3717±372.2 | 5256±304.3* | 1585±108.9 | 3297±146.2* |
TRAIL | 135.7±13.64 | 209.2±6.82 | 151.4±10.16 | 191.9±5.06* |
β-NGF | 23.92±1.76 | 23.81±2.23 | 20.50±1.17 | 24.12±2.39 |
LIF | 114.9±11.92 | 227.4±6.7* | 64.70±2.41 | 212.7±15.88* |
HGF | 63.33±4.98 | 81.84±1.41* | 71.23±1.47 | 69.34±1.71 |
CTAK/ CCL27 | 130.5±9.87 | 249.3±9.73* | 122.5±2.40 | 211.7±8.91* |
SDF-1α/CXCL12 | 672.0±31.7 | 1504±97.33* | 121.6±9.61 | 359.4±28.6* |
SCGF-β | 685.7±32.1 | 1000±73.1* | 3575±191.2 | 5905±161.9* |
SCF | 19.09±1.08 | 42.87±0.18* | 27.50±1.52 | 38.66±3.03* |